IGR Anti-Obesity Prescription Drugs Market | Seite 2

The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and
naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group
(pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the
main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-
Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024.
The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this
market.
Get a Sample Request
https://www.infiniumglobalresearch.com/reports/sample_request/1127
Market Insight
The pharmacological agents that helps to reduce or control weight. Anti-obesity drugs help in reducing body mass either by
reducing the hunger or increasing the consumption of calories. The ingesting of unhealthy food which is rich in cholesterol has
increased which leads to a rise in demand for anti-obesity prescription drugs. Rising level of chronic stress also contributes
towards obesity.Rising consumption of alcoholic beverages and unhealthy food which is rich in cholesterol that leads to
obesity is driving the growth of the market. Growing occurrence of depression has led to growing consumption of the
psychotropic drugs; the side effect of this drug is increasing which result to obesity. Moreover, increasing incidences of
diabetes have surged up the consumption of medications. These medications have appetite stimulating features, due to which
the patients incline to eat more. Eating disorders due to antidepressants and diabetic drugs increase the diet which has
sustained to contribute towards obesity. Growing demand for obesity management is expected to impact growth of the global
anti-obesity prescription drugs market positively.
Segment Covered
The report on global anti-obesity prescription drugs market covers segments such as, drug class, distribution channel and age
group. On the basis of drug class the global anti-obesity prescription drugs market is categorized into orlistat, phentermine
and topiramate, bupropion and naltrexone, lorcaserin and liraglutide. On the basis of distribution channel the global anti-
obesity prescription drugs market is categorized into retail pharmacy, hospital pharmacy and online pharmacy. On the basis of
age group the global anti-obesity prescription drugs market is categorized into pediatric and adult.
Infinium Global Research